Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toyonobu Uzawa

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Calcium|January 11, 2007
[Therapeutic agents for disorders of bone and calcium metabolism--Parathyroid hormone in weekly subcutaneous injection]Toyonobu Uzawa
Journal of Bone and Mineral Metabolism|January 3, 2021
Twice-weekly teriparatide improves lumbar spine BMD independent of pre-treatment BMD and bone turnover marker levelsJunichi Takada, Takeshi Yoshimura, Toyonobu Uzawa
Osteoporosis and Sarcopenia|April 19, 2021
Efficacy of once-weekly and twice-weekly injections of teriparatide by patient characteristics: A post hoc analysis of the TWICE studyToshitsugu Sugimoto, Takeshi Yoshimura, Toyonobu Uzawa
Osteoporosis and Sarcopenia|July 25, 2019
Safety and efficacy in actual clinical practice of once-weekly subcutaneous teriparatide for osteoporosis patients with a high fracture riskEmiko Ifuku, Takeshi Yoshimura, Toyonobu Uzawa, et al.
Osteoporosis and Sarcopenia|April 1, 2020
Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosisHiroaki Okamoto, Nayumi Shibazaki, Takeshi Yoshimura, et al.
Bone|August 21, 2007
Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized ratsYuki Washimi, Masato Ito, Yosuke Morishima, et al.
Scientific Reports|November 20, 2018
Endogenous calcitonin regulates lipid and glucose metabolism in diet-induced obesity miceMisa Nakamura, Sachiko Nomura, Tadashi Yamakawa, et al.
Springerplus|May 24, 2014
Once-weekly teriparatide increases bone mineral density in the distal 1/10 radius, but not in the distal 1/3 radiusNobuo Urushibara, Naoto Kato, Ryutaro Adachi, et al.
Modern Rheumatology Case Reports|November 18, 2021
Bone microstructure changes due to once-/twice-weekly teriparatide administration: A report of five cases using high-resolution peripheral quantitative computed tomographyManabu Tsukamoto, Nobukazu Okimoto, Miyuki Mori, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Calcium|January 11, 2007
[Therapeutic agents for disorders of bone and calcium metabolism--Parathyroid hormone in weekly subcutaneous injection]Toyonobu Uzawa
Journal of Bone and Mineral Metabolism|January 3, 2021
Twice-weekly teriparatide improves lumbar spine BMD independent of pre-treatment BMD and bone turnover marker levelsJunichi Takada, Takeshi Yoshimura, Toyonobu Uzawa
Osteoporosis and Sarcopenia|April 19, 2021
Efficacy of once-weekly and twice-weekly injections of teriparatide by patient characteristics: A post hoc analysis of the TWICE studyToshitsugu Sugimoto, Takeshi Yoshimura, Toyonobu Uzawa
Osteoporosis and Sarcopenia|July 25, 2019
Safety and efficacy in actual clinical practice of once-weekly subcutaneous teriparatide for osteoporosis patients with a high fracture riskEmiko Ifuku, Takeshi Yoshimura, Toyonobu Uzawa, et al.
Osteoporosis and Sarcopenia|April 1, 2020
Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosisHiroaki Okamoto, Nayumi Shibazaki, Takeshi Yoshimura, et al.
Bone|August 21, 2007
Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized ratsYuki Washimi, Masato Ito, Yosuke Morishima, et al.
Scientific Reports|November 20, 2018
Endogenous calcitonin regulates lipid and glucose metabolism in diet-induced obesity miceMisa Nakamura, Sachiko Nomura, Tadashi Yamakawa, et al.
Springerplus|May 24, 2014
Once-weekly teriparatide increases bone mineral density in the distal 1/10 radius, but not in the distal 1/3 radiusNobuo Urushibara, Naoto Kato, Ryutaro Adachi, et al.
Modern Rheumatology Case Reports|November 18, 2021
Bone microstructure changes due to once-/twice-weekly teriparatide administration: A report of five cases using high-resolution peripheral quantitative computed tomographyManabu Tsukamoto, Nobukazu Okimoto, Miyuki Mori, et al.
Pageof 1